| | Eli Lilly and Co said on Monday that its top-selling diabetes drug Trulicity significantly reduced the risk of heart attack, stroke and heart-related death in a broad range of people with type 2 diabetes, according to results of a large clinical trial. | |
| China confirmed a new case of African swine fever on Monday, in southern Hunan province, marking the 50th outbreak of the highly contagious disease in the world's top pork producer. | |
| Novartis International AG said on Friday that its Sandoz division is abandoning an effort to gain U.S. regulatory approval for a biosimilar of rituximab, a medication used to treat certain cancer and rheumatoid arthritis. | |
| Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation who had been previously treated for an aggressive form of the disease. | |
| An advisory panel to the U.S. Food and Drug Administration on Friday recommended Sage Therapeutics Inc's experimental treatment for postpartum depression, saying the benefits of the drug outweighed risks. | |
| The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval in a rare move. | |
| (Reuters Health) - Teens seeking to buy emergency contraception at pharmacies continue to face significant roadblocks, a new U.S. study suggests. | |
| (Reuters Health) - Standing above the crowd puts people at greater risk of developing varicose veins, a large genetic study suggests. | |
| Trevena Inc shares plunged 45 percent on Friday after the U.S. Food and Drug Administration declined to approve its opioid injection for managing acute pain, citing inadequate safety data. | |
| (Reuters Health) - People with insomnia who receive a digitized version of cognitive behavioral therapy (CBT) as part of their treatment may find more symptom relief than those who only receive tips to improve their sleep routines, a recent experiment suggests. | |
| (Reuters Health) - Publicly-available ratings of U.S. hospital quality for heart surgery vary so widely from one another they may be more confusing than helpful for patients trying to pick the best place to have a procedure, researchers say. | |
|
| |